DiaSorin S.p.A. (OTCMKTS:DSRLF – Get Free Report) was the recipient of a significant increase in short interest during the month of December. As of December 31st, there was short interest totalling 54,100 shares, an increase of 14.6% from the December 15th total of 47,200 shares. Based on an average daily volume of 100 shares, the days-to-cover ratio is currently 541.0 days.
Wall Street Analysts Forecast Growth
Separately, UBS Group cut DiaSorin from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, November 26th.
View Our Latest Research Report on DiaSorin
DiaSorin Stock Performance
About DiaSorin
DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS.
See Also
- Five stocks we like better than DiaSorin
- Health Care Stocks Explained: Why You Might Want to Invest
- Top ETFs That Beat the Market in 2024 and Could Do It Again
- What Are Dividend Champions? How to Invest in the Champions
- J.B. Hunt Leads Truckers Lower: Buy Them While They’re Down?
- How to Find Undervalued Stocks
- MarketBeat Week in Review – 01/13 – 01/17
Receive News & Ratings for DiaSorin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DiaSorin and related companies with MarketBeat.com's FREE daily email newsletter.